Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
IGM Biosciences logo

IGM Biosciences

Recent Finacing

Series C

Recent Raise

$102M

IGM Biosciences is a Mountain View-based biotech developing engineered IgM antibodies via a proprietary IgM platform for oncology, advancing a CD20×CD3 bispecific into clinical trials.

Founded 2010
California, United States
251-500
Publicly Traded
igmbio.com

Highlights

Focus Areas

Biotechnology
Medical
Therapeutics

Recent Investors

Vivo Capital logo
Janus Henderson Investors logo
Haldor Topsoe Holding logo
Redmile Group logo

Financials

$102M

Total Raised

1

Funding round

4

Investors


Team

Upgrade to view the team

See the team members at IGM Biosciences.